Gastritis

GASTRITIS

Latest Articles

General Gastroenterology

Alcohol-Related GI and Liver Disease Rates Increase in Women, Black Patients During COVID-19 Pandemic

By

heartburn chest woman

General Gastroenterology

Rosacea Linked to Increased Prevalence of Upper GI Disorders

By

Fatty liver, conceptual illustration. Fatty liver is commonly associated with alcohol or metabolic syndrome (diabetes, hypertension and obesity), but can also be due to any one of many causes. Fatty liver disease is a reversible condition wherein large vacuoles of fat (pale yellow circles) accumulate in liver cells.

Stomach Disorders

Oral Prodrug of Testosterone Fast Tracked for Nonalcoholic Steatohepatitis

By

Brian Park, PharmD

Stomach Disorders

Protective Effects of Glucocorticoids and Androgens Against Gastric Inflammation

By

Bradley van Paridon

gastritis

Long-Term Lirentelimab Therapy Improves Symptoms of Eosinophilic Gastritis and/or Duodenitis

By

Jessica Nye, PhD

Stomach Disorders

Assessment of Helicobacter pylori Antibody Type on Serum Gastric Function

By

CKD

H pylori infection

Association Between Helicobacter pylori Infection and Chronic Kidney Disease

By

h pylori

H pylori infection

Routine Examinations for Helicobacter pylori in Chronic Peptic Duodenitis May Not Be Needed

By

Stomach Disorders

Factors Contributing to Delay in Diagnosis of Eosinophilic Gastritis and Duodenitis

By

Clostridium difficile

Other bowel disorders

Gastrointestinal Infection Is Associated With Increased Risk of Microscopic Colitis

By

H pylori infection

Anti-Helicobacter pylori Therapy Benefits Those at High Risk for Gastric Cancer

By

Jessica Nye, PhD

endoscope

Stomach Disorders

First Surveillance Endoscopy Three Years After Atrophic Gastritis Diagnosis Appears Safe

By

Stomach Disorders

EGID Without Eosinophilia: Elevated Mucosal Mast Cell Counts

By

Gastroenterology Advisor Contributing Writer

Stomach Disorders

Teplizumab Gets Breakthrough Status for Type 1 Diabetes Prevention

By

Probiotics are often used as an adjunct or nonpharmacological approach to treating various forms of arthritis, but studies have shown mixed results. A 12-week study assessing the effect of an orally administered probiotic on disease activity, fatigue, quality of life, and intestinal symptoms in patients with active SpA demonstrated no significant benefit over placebo.16 In contrast, a study assessing 8 weeks of Lactobacillus casei 01 supplementation in patients with RA showed improvements in disease activity and inflammatory status versus placebo.17 A major challenge with studying probiotics is the complexity of selecting the strains and formulations most likely to have a beneficial impact on the microbiome of the arthritis type studied. Furthermore, sufficient randomized clinical trials to guide clinical practice are lacking. Until more definitive data are available, decisions on probiotics are likely to continue to be guided by anecdotal evidence. Photo credit: MicroScape / Science Source

Efficacy of Lactobacillus reuteri for Acute Gastroenteritis in Children

By

Gastroenterology Advisor Contributing Writer